Cargando…

Targeting HDAC Complexes in Asthma and COPD

Around three million patients die due to airway inflammatory diseases each year. The most notable of these diseases are asthma and chronic obstructive pulmonary disease (COPD). Therefore, new therapies are urgently needed. Promising targets are histone deacetylases (HDACs), since they regulate postt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zwinderman, Martijn R. H., de Weerd, Sander, Dekker, Frank J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594684/ https://www.ncbi.nlm.nih.gov/pubmed/34968229 http://dx.doi.org/10.3390/epigenomes3030019

Ejemplares similares

Inhibition of histone deacetylase 1 (HDAC1) and HDAC2 enhances CRISPR/Cas9 genome editing
por: Liu, Bin, et al.
Publicado: (2020)

The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
por: Cao, Fangyuan, et al.
Publicado: (2018)

Cytokine-targeted therapies for asthma and COPD
por: Schleich, Florence, et al.
Publicado: (2023)

Airflow obstruction: is it asthma or is it COPD?
por: Rogliani, Paola, et al.
Publicado: (2016)

Reduced HDAC2 in skeletal muscle of COPD patients
por: To, Masako, et al.
Publicado: (2017)

Asthma–COPD overlap: identification and optimal treatment
por: Cosío, Borja G., et al.
Publicado: (2018)

Pragmatic research and outcomes in asthma and COPD
por: Colice, Gene L
Publicado: (2012)

Treatment Response Biomarkers in Asthma and COPD
por: Meteran, Howraman, et al.
Publicado: (2021)

Clinically relevant subgroups in COPD and asthma
por: Turner, Alice M., et al.
Publicado: (2015)

COPD stands for complex obstructive pulmonary disease
por: Houben-Wilke, Sarah, et al.
Publicado: (2018)

ACO (Asthma–COPD Overlap) Is Independent from COPD: The Case Against
por: Calverley, Peter M. A., et al.
Publicado: (2021)

Novel therapeutic approaches to simultaneously target rhinovirus infection and asthma/COPD pathogenesis
por: Mirabelli, Carmen, et al.
Publicado: (2017)

Asthma and COPD
por: Enright, Paul, et al.
Publicado: (2012)

Muscarinic receptor signaling in the pathophysiology of asthma and COPD
por: Gosens, Reinoud, et al.
Publicado: (2006)

Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts
por: Joo, Hyonsoo, et al.
Publicado: (2022)

Bronchodilator Response in Patients with COPD, Asthma-COPD-Overlap (ACO) and Asthma, Evaluated by Plethysmographic and Spirometric z-Score Target Parameters
por: Kraemer, Richard, et al.
Publicado: (2021)

Rhinovirus-Induced Exacerbations of Asthma and COPD
por: Hershenson, Marc B.
Publicado: (2013)

TSLP and HMGB1: Inflammatory Targets and Potential Biomarkers for Precision Medicine in Asthma and COPD
por: Furci, Fabiana, et al.
Publicado: (2023)

Fatigue, Depression, and Anxiety in Patients with COPD, Asthma and Asthma-COPD Overlap
por: Homętowska, Henryka, et al.
Publicado: (2022)

The Role of the Body Clock in Asthma and COPD: Implication for Treatment
por: Krakowiak, Karolina, et al.
Publicado: (2018)

HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
por: Simões-Pires, Claudia, et al.
Publicado: (2013)

Network of phosphatases and HDAC complexes at repressed chromatin
por: de Castro, I. J., et al.
Publicado: (2017)

Is this asthma, COPD, or both?
por: Neder, José Alberto, et al.
Publicado: (2021)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD
por: Calderon, Ariel A., et al.
Publicado: (2023)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

Health characteristics of patients with asthma, COPD and asthma–COPD overlap in the NHANES database
por: Llanos, Jean-Pierre, et al.
Publicado: (2018)

Coronary heart disease and heart failure in asthma, COPD and asthma-COPD overlap
por: Ingebrigtsen, Truls Sylvan, et al.
Publicado: (2020)

Mucus Plugs and Small Airway Dysfunction in Asthma, COPD, and Asthma-COPD Overlap
por: Tamura, Kanami, et al.
Publicado: (2022)

Choosing the right inhaler for your asthma or COPD patient
por: Usmani, Omar S
Publicado: (2019)

New insights to improve treatment adherence in asthma and COPD
por: George, Maureen, et al.
Publicado: (2019)

The role of the bronchial microvasculature in the airway remodelling in asthma and COPD
por: Zanini, Andrea, et al.
Publicado: (2010)

Inter- and transgenerational epigenetic inheritance: evidence in asthma and COPD?
por: Krauss-Etschmann, Susanne, et al.
Publicado: (2015)

Pharmacological mechanism of roflumilast in the treatment of asthma–COPD overlap
por: Zhang, Xiaoli, et al.
Publicado: (2018)

Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD
por: Lewis, Brandon W., et al.
Publicado: (2021)

Identifying risk factors for COPD and adult-onset asthma: an umbrella review
por: Holtjer, Judith C.S., et al.
Publicado: (2023)

Prevalence of Asthma Characteristics in COPD Patients in a Dutch Well-Established Asthma/COPD Service for Primary Care
por: Baron, Anna Jetske, et al.
Publicado: (2020)

Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors
por: Thomas, Elizabeth A.
Publicado: (2014)

The molecular mechanisms of remodeling in asthma, COPD and IPF with a special emphasis on the complex role of Wnt5A
por: Singla, Abhinav, et al.
Publicado: (2023)

Risk of Malignancy in Patients with Asthma-COPD Overlap Compared to Patients with COPD without Asthma
por: Bonnesen, Barbara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56htak5q7u56cs4a0pn27tltpp